NCT01102309

Brief Summary

The goal of this study is to determine if robot aided rehabilitation therapy can be equivalent to or more effective than conventional rehabilitation therapy at promoting functional recovery of the paretic upper limb in acute and subacute stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Oct 2008

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 13, 2010

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

June 27, 2011

Status Verified

June 1, 2011

Enrollment Period

2.7 years

First QC Date

April 8, 2010

Last Update Submit

June 23, 2011

Conditions

Keywords

cerebrovascular accidenthemiparesisrecovery of functionrehabilitationroboticssubacute therapytraining

Outcome Measures

Primary Outcomes (3)

  • Fugl-Meyer (FM-SEC and FM-WH)

    Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the test includes items related to movements of the shoulder, elbow, forearm (proximal arm), and wrist and hand (distal arm). The total scores range between 0 and 66. We considered the shoulder/elbow and coordination subsections (FM-SEC = 42/66 items) and the wrist/hand subsection (FM-WH = 24/66 items).

    7 months

  • Motor-Functional Independence Measure (m-FIM)

    Motor-Functional Independent Measure (m-FIM) is a test to measure improvements in basic motor ADL, outcomes and the degree of self-care. The motor-FIM is a subsection of Functional Indipendence Measure that is an ordinal scale that assesses severity of motor disability, composed of 13-item motor subscale (including self-care, sphincter control, mobility, locomotion) with a scoring ranges between 13 and 91; each item envisages 7 levels of performance independence (7 is total independence, 1 is total dependence or unassessable).

    7 months

  • Frenchay Arm Test (FA-T)

    Franchey Arm Test (FA-T) evaluates five activities of daily living: lifting and replacing of a glass, drawing a line with the use of a ruler, combing the hair, lifting and replacing of a cylinder \[5 cm long\], removing of a sprung clothes peg from a dowel and replacing it; 0 = worst score; 5 = best score).It reflects both hand and arm functions.

    7 months

Secondary Outcomes (8)

  • Medical Research Council (MRC deltoid, biceps, triceps, wrist flexor, wrist extensor)

    7 months

  • Modified Ashworth Scale (MAS)

    7 months

  • Functional Independent Measure (FIM)

    7 months

  • Fatigue Severity Scale (FSS)

    7 months

  • Upper-Motricity Index (upMI)

    7 months

  • +3 more secondary outcomes

Study Arms (2)

Experimental Group (EG)

EXPERIMENTAL

Group assigned to robot plus conventional therapy

Device: Robot therapy (NeReBot)Other: Conventional therapy

Control Group (CG)

ACTIVE COMPARATOR

Group assigned to conventional therapy only

Other: Conventional therapy

Interventions

Rehabilitation therapy of the affected arm with NeRebot for five weeks, five times weekly for 40 minutes, plus 80 minutes of conventional therapy

Experimental Group (EG)

Conventional rehabilitation therapy of the affected arm for five weeks, five times weekly for 120 minutes

Control Group (CG)Experimental Group (EG)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • recent unilateral single stroke (ischemic or hemorrhagic) verified by brain CT or MRI;
  • sufficient cognitive and language skills to understand the instructions of the operator (assessed by Modified Mini-Mental State Examination \> 21);
  • patients with upper limb paralysis (Motor Power score between 8 and 12);
  • written informed consent signed by the patient (or an authorized representative).

You may not qualify if:

  • cardiovascular instability (severe uncontrolled hypertension, severe coronary artery disease, etc.) or orthopedic, or neurological conditions;
  • presence of multiple cerebrovascular lesions (usually the result of many ischemic episodes in the past);
  • early appearance of marked spasticity (≥ 3 according to Ashworth Scale);
  • joint pain or limited joint range of motion (ROM) of the upper limb that results in the inability to complete the protocol;
  • severe neuropsychologic impairment (global aphasia, severe attention deficit or neglect), affecting the patient's ability to follow instructions;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eremo Hospital of Arco

Arco, TN, I-38062, Italy

Location

Related Publications (2)

  • Masiero S, Armani M, Rosati G. Upper-limb robot-assisted therapy in rehabilitation of acute stroke patients: focused review and results of new randomized controlled trial. J Rehabil Res Dev. 2011;48(4):355-66. doi: 10.1682/jrrd.2010.04.0063.

  • Masiero S, Armani M, Ferlini G, Rosati G, Rossi A. Randomized trial of a robotic assistive device for the upper extremity during early inpatient stroke rehabilitation. Neurorehabil Neural Repair. 2014 May;28(4):377-86. doi: 10.1177/1545968313513073. Epub 2013 Dec 6.

Related Links

MeSH Terms

Conditions

StrokeParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mario Armani, MD

    Eremo Hospital, Arco

    STUDY DIRECTOR
  • Stefano Masiero, MD

    University of Padova

    PRINCIPAL INVESTIGATOR
  • Giulio Rosati, PhD

    University of Padova

    STUDY CHAIR
  • Aldo Rossi

    University of Padova

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 8, 2010

First Posted

April 13, 2010

Study Start

October 1, 2008

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

June 27, 2011

Record last verified: 2011-06

Locations